Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cutting Edge Information

Explore full profile

The FMV Data Provider to more than 20 of the Top 25 Pharmaceutical Companies

Durham, United StatesFounded 2002Biotech & Life Sciences
Valuation $50–100M Last recorded · 2007
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cutting Edge Information and the history behind them.

About Cutting Edge Information

Cutting Edge Information is a market research and consulting firm that serves the pharmaceutical, biotechnology, and medical device industries. The company provides benchmarking data, best practices, and decision support to its clients through research reports and a subscription-based online platform called FMVConnect PRO.

Its primary focus is on providing Fair Market Value (FMV) data and compliance solutions for healthcare professional (HCP) engagement. This helps life sciences companies ensure that their payments to physicians and other HCPs for activities like consulting, speaking, and advisory boards are compliant with regulations.

The company's business model is based on selling its research reports and subscriptions to its FMVConnect PRO platform. It also offers custom research and consulting services. Its clients are primarily life sciences companies, including pharmaceutical and biotech firms.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2002
Headquarters
Durham, United States
Employees
33
Open positions
None listed
Dealroom signal
56.3/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jun 2007 $16M $63M Stanley Medical Research Institute · Intersouth Partners · Amgen Ventures —
SERIES A✓Equity / VC Sep 2003 $1M $4M Stanley Medical Research Institute —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Cutting Edge Information website traffic

Latest recorded traffic for Cutting Edge Information is 1.4K monthly website visits, up 154.5% over the last three months. Cutting Edge Information's team grew 0% over the past year.

Latest monthly visits1.4K 3-month web change+154.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
New American TherapeuticsA privately held, specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas Parsippany-Troy Hills, United States Operational — $53M —
Steel TherapeuticsFocused on increasing access to life-changing therapies with a track record of efficacy from compounding pharmacies Iowa City, United States Operational
CellmAbsCellmabs is focused on researching and developing innovative biopharmaceuticals for the treatment of cancer Óbidos, Portugal Acquired
ImmuneOnco BiopharmaDedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells Huangpu, China Operational
AutolusProgrammed T-cell immunotherapies for cancer and autoimmune diseases London, United Kingdom Operational
UppertonPharmaceutical CDMO for oral and nasal dosage forms Nottingham, United Kingdom Operational
Caris Life SciencesA profiling platform that identifies novel molecular targets to inform and enhance drug development and advanced diagnostics Irving, United States Operational
Leap TherapeuticsA biopharmaceutical company in the clinical stage, acquiring and advancing innovative therapeutics at the forefront of cancer research Cambridge, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Stanley Medical Research Institute
  • Intersouth Partners
  • Amgen Ventures
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cutting Edge Information on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cutting Edge Information’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.